Article info

Original research
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma

Authors

  1. Correspondence to Professor Patrizia Stoitzner; patrizia.stoitzner{at}i-med.ac.at
View Full Text

Citation

Hornsteiner F, Vierthaler J, Strandt H, et al
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma

Publication history

  • Accepted March 25, 2024
  • First published April 17, 2024.
Online issue publication 
April 17, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.